ID   ARK73_HUMAN             Reviewed;         331 AA.
AC   O95154; Q86SR4; Q8IVN6; Q8N5V6; Q8TAX1; Q9NUC3;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   12-APR-2017, entry version 148.
DE   RecName: Full=Aflatoxin B1 aldehyde reductase member 3;
DE            EC=1.-.-.-;
DE   AltName: Full=AFB1 aldehyde reductase 2;
DE            Short=AFB1-AR 2;
GN   Name=AKR7A3; Synonyms=AFAR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANTS MET-138;
RP   ASP-215 AND ALA-323.
RC   TISSUE=Liver;
RX   PubMed=10383892; DOI=10.1093/carcin/20.7.1215;
RA   Knight L.P., Primiano T., Groopman J.D., Kensler T.W., Sutter T.R.;
RT   "cDNA cloning, expression and activity of a second human aflatoxin B1-
RT   metabolizing member of the aldo-keto reductase superfamily, AKR7A3.";
RL   Carcinogenesis 20:1215-1223(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS ASP-215
RP   AND ALA-323.
RX   PubMed=12879023; DOI=10.1038/sj.onc.1206684;
RA   Praml C., Savelyeva L., Schwab M.;
RT   "Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1
RT   in a region frequently altered in human tumour cells.";
RL   Oncogene 22:4765-4773(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS MET-138; ASP-215
RP   AND ALA-323.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=18416522; DOI=10.1021/tx7004458;
RA   Bodreddigari S., Jones L.K., Egner P.A., Groopman J.D., Sutter C.H.,
RA   Roebuck B.D., Guengerich F.P., Kensler T.W., Sutter T.R.;
RT   "Protection against aflatoxin B1-induced cytotoxicity by expression of
RT   the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human
RT   AKR7A3.";
RL   Chem. Res. Toxicol. 21:1134-1142(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85 AND THR-227, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 8-331 IN COMPLEX WITH NADP,
RP   AND SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human aflatoxin B1 aldehyde reductase member
RT   3.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Can reduce the dialdehyde protein-binding form of
CC       aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be
CC       involved in protection of liver against the toxic and carcinogenic
CC       effects of AFB1, a potent hepatocarcinogen.
CC       {ECO:0000269|PubMed:18416522}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.7}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-748869, EBI-748869;
CC       O43488:AKR7A2; NbExp=3; IntAct=EBI-748869, EBI-748855;
CC       Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-748869, EBI-750109;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed in colon, kidney, liver, pancreas,
CC       adenocarcinoma and endometrium. {ECO:0000269|PubMed:12879023,
CC       ECO:0000269|PubMed:18416522}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. Aldo/keto
CC       reductase 2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF040639; AAD02195.1; -; mRNA.
DR   EMBL; AJ271799; CAC81076.1; -; mRNA.
DR   EMBL; AL035413; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025709; AAH25709.1; -; mRNA.
DR   EMBL; BC031562; AAH31562.1; -; mRNA.
DR   EMBL; BC042420; AAH42420.2; -; mRNA.
DR   CCDS; CCDS193.1; -.
DR   RefSeq; NP_036199.2; NM_012067.2.
DR   UniGene; Hs.6980; -.
DR   PDB; 2CLP; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K=8-331.
DR   PDBsum; 2CLP; -.
DR   ProteinModelPortal; O95154; -.
DR   SMR; O95154; -.
DR   BioGrid; 116626; 10.
DR   IntAct; O95154; 8.
DR   MINT; MINT-1435043; -.
DR   STRING; 9606.ENSP00000355377; -.
DR   iPTMnet; O95154; -.
DR   PhosphoSitePlus; O95154; -.
DR   BioMuta; AKR7A3; -.
DR   MaxQB; O95154; -.
DR   PaxDb; O95154; -.
DR   PeptideAtlas; O95154; -.
DR   PRIDE; O95154; -.
DR   DNASU; 22977; -.
DR   Ensembl; ENST00000361640; ENSP00000355377; ENSG00000162482.
DR   GeneID; 22977; -.
DR   KEGG; hsa:22977; -.
DR   UCSC; uc001bbv.2; human.
DR   CTD; 22977; -.
DR   GeneCards; AKR7A3; -.
DR   H-InvDB; HIX0000196; -.
DR   HGNC; HGNC:390; AKR7A3.
DR   HPA; HPA064638; -.
DR   MIM; 608477; gene.
DR   neXtProt; NX_O95154; -.
DR   OpenTargets; ENSG00000162482; -.
DR   PharmGKB; PA24683; -.
DR   eggNOG; ENOG410IDYD; Eukaryota.
DR   eggNOG; COG0667; LUCA.
DR   GeneTree; ENSGT00550000074567; -.
DR   HOGENOM; HOG000250286; -.
DR   HOVERGEN; HBG050576; -.
DR   InParanoid; O95154; -.
DR   KO; K15303; -.
DR   OMA; AFVYSEG; -.
DR   OrthoDB; EOG091G0BTK; -.
DR   PhylomeDB; O95154; -.
DR   TreeFam; TF329173; -.
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   SABIO-RK; O95154; -.
DR   EvolutionaryTrace; O95154; -.
DR   GenomeRNAi; 22977; -.
DR   PRO; PR:O95154; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162482; -.
DR   CleanEx; HS_AKR7A3; -.
DR   Genevisible; O95154; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:Reactome.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   SUPFAM; SSF51430; SSF51430; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; NAD; NADP; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    331       Aflatoxin B1 aldehyde reductase member 3.
FT                                /FTId=PRO_0000070378.
FT   NP_BIND     143    144       NADP. {ECO:0000269|Ref.7}.
FT   NP_BIND     198    208       NADP. {ECO:0000269|Ref.7}.
FT   NP_BIND     290    298       NADP. {ECO:0000269|Ref.7}.
FT   ACT_SITE     49     49       Proton donor. {ECO:0000250}.
FT   BINDING      44     44       NADP. {ECO:0000269|Ref.7}.
FT   BINDING     113    113       Substrate. {ECO:0000250}.
FT   BINDING     169    169       NADP. {ECO:0000250}.
FT   BINDING     222    222       NADP. {ECO:0000269|Ref.7}.
FT   BINDING     232    232       Substrate. {ECO:0000250}.
FT   BINDING     235    235       Substrate. {ECO:0000250}.
FT   SITE         77     77       Lowers pKa of active site Tyr.
FT                                {ECO:0000250}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P38918}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     227    227       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     138    138       V -> M (in dbSNP:rs2231198).
FT                                {ECO:0000269|PubMed:10383892,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_017416.
FT   VARIANT     215    215       N -> D (in dbSNP:rs1738023).
FT                                {ECO:0000269|PubMed:10383892,
FT                                ECO:0000269|PubMed:12879023,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_017417.
FT   VARIANT     323    323       T -> A (in dbSNP:rs1738025).
FT                                {ECO:0000269|PubMed:10383892,
FT                                ECO:0000269|PubMed:12879023,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_017418.
FT   CONFLICT     51     51       E -> D (in Ref. 1; AAD02195).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       L -> P (in Ref. 4; AAH42420).
FT                                {ECO:0000305}.
FT   STRAND       11     15       {ECO:0000244|PDB:2CLP}.
FT   TURN         20     22       {ECO:0000244|PDB:2CLP}.
FT   HELIX        25     36       {ECO:0000244|PDB:2CLP}.
FT   TURN         37     39       {ECO:0000244|PDB:2CLP}.
FT   STRAND       42     44       {ECO:0000244|PDB:2CLP}.
FT   HELIX        49     52       {ECO:0000244|PDB:2CLP}.
FT   HELIX        53     59       {ECO:0000244|PDB:2CLP}.
FT   STRAND       67     69       {ECO:0000244|PDB:2CLP}.
FT   STRAND       73     78       {ECO:0000244|PDB:2CLP}.
FT   HELIX        88    102       {ECO:0000244|PDB:2CLP}.
FT   STRAND      107    112       {ECO:0000244|PDB:2CLP}.
FT   HELIX       121    133       {ECO:0000244|PDB:2CLP}.
FT   STRAND      136    144       {ECO:0000244|PDB:2CLP}.
FT   HELIX       147    160       {ECO:0000244|PDB:2CLP}.
FT   STRAND      165    171       {ECO:0000244|PDB:2CLP}.
FT   HELIX       178    180       {ECO:0000244|PDB:2CLP}.
FT   HELIX       183    190       {ECO:0000244|PDB:2CLP}.
FT   STRAND      193    197       {ECO:0000244|PDB:2CLP}.
FT   HELIX       201    206       {ECO:0000244|PDB:2CLP}.
FT   HELIX       211    214       {ECO:0000244|PDB:2CLP}.
FT   TURN        215    217       {ECO:0000244|PDB:2CLP}.
FT   STRAND      220    226       {ECO:0000244|PDB:2CLP}.
FT   HELIX       229    236       {ECO:0000244|PDB:2CLP}.
FT   HELIX       239    256       {ECO:0000244|PDB:2CLP}.
FT   HELIX       257    259       {ECO:0000244|PDB:2CLP}.
FT   HELIX       263    274       {ECO:0000244|PDB:2CLP}.
FT   HELIX       279    281       {ECO:0000244|PDB:2CLP}.
FT   STRAND      284    287       {ECO:0000244|PDB:2CLP}.
FT   HELIX       292    303       {ECO:0000244|PDB:2CLP}.
FT   HELIX       309    322       {ECO:0000244|PDB:2CLP}.
FT   HELIX       323    325       {ECO:0000244|PDB:2CLP}.
SQ   SEQUENCE   331 AA;  37206 MW;  B9C32C33C7102AB3 CRC64;
     MSRQLSRARP ATVLGAMEMG RRMDAPTSAA VTRAFLERGH TEIDTAFVYS EGQSETILGG
     LGLRLGGSDC RVKIDTKAIP LFGNSLKPDS LRFQLETSLK RLQCPRVDLF YLHMPDHSTP
     VEETLRACHQ LHQEGKFVEL GLSNYAAWEV AEICTLCKSN GWILPTVYQG MYNAITRQVE
     TELFPCLRHF GLRFYAFNPL AGGLLTGKYK YEDKNGKQPV GRFFGNTWAE MYRNRYWKEH
     HFEGIALVEK ALQAAYGASA PSMTSATLRW MYHHSQLQGA HGDAVILGMS SLEQLEQNLA
     AAEEGPLEPA VVDAFNQAWH LVTHECPNYF R
//
